111 related articles for article (PubMed ID: 7526079)
1. Induction of cell surface interleukin 2 receptor alpha chain expression on non-T lymphoid leukemia cells.
Nakase K; Kita K; Shirakawa S; Tanaka I; Tsudo M
Leuk Res; 1994 Nov; 18(11):855-9. PubMed ID: 7526079
[TBL] [Abstract][Full Text] [Related]
2. Induction of interleukin-2 receptor alpha chain expression of immature acute myelocytic leukemia cells.
Nakase K; Kita K; Anazawa H; Hoshino K; Shirakawa S; Tanaka I; Tsudo M
Leuk Res; 1994 Apr; 18(4):269-74. PubMed ID: 7513371
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of interleukin-2 receptors (alpha and beta chain) in mature lymphoid neoplasms.
Nakase K; Kita K; Nasu K; Ueda T; Tanaka I; Shirakawa S; Tsudo M
Am J Hematol; 1994 Jul; 46(3):179-83. PubMed ID: 7514848
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and clinical importance of interleukin-2 receptor alpha chain expression on non-T-cell acute leukaemia cells.
Nakase K; Kita K; Otsuji A; Anazawa H; Hoshino K; Sekine T; Shirakawa S; Tanaka I; Nasu K; Tsutani H
Br J Haematol; 1992 Mar; 80(3):317-26. PubMed ID: 1581211
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of interleukin-2 receptor alpha-chain expression in acute leukemia. The Japan Cooperative Group of Leukemia/Lymphoma.
Nakase K; Kita K; Kageyama S; Tsuji K; Miyanishi E; Miwa H; Tanaka I; Shirakawa S; Tanaka I; Anazawa H; Tsutani H; Kyo T; Dohy H; Kamada N; Doi S; Nasu K; Uchino H
Cancer Detect Prev; 1997; 21(3):273-9. PubMed ID: 9167045
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
8. Presence of a p70 IL-2-binding peptide on leukemic cells from various hemopoietic lineages.
Allouche M; Sahraoui Y; Augery-Bourget Y; Ohashi Y; Sugamura K; Jasmin C; Georgoulias V
J Immunol; 1989 Oct; 143(7):2223-9. PubMed ID: 2789258
[TBL] [Abstract][Full Text] [Related]
9. [A study on interleukin-2 receptor genes in acute myeloid leukemia cells].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):288-92. PubMed ID: 10684036
[TBL] [Abstract][Full Text] [Related]
10. Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer.
Dickerson EB; Fosmire S; Padilla ML; Modiano JF; Helfand SC
J Immunother; 2002; 25(1):36-45. PubMed ID: 11924909
[TBL] [Abstract][Full Text] [Related]
11. [The responses of leukemia cells to interleukin-2 in vitro].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):188-92. PubMed ID: 10683932
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.
Ohyashiki K; Miyauchi J; Ohyashiki JH; Saito M; Yaguchi M; Inatomi Y; Nakazawa S; Waca H; Mizutani S; Matsuo Y
Leukemia; 1993 Jul; 7(7):1034-40. PubMed ID: 7686604
[TBL] [Abstract][Full Text] [Related]
14. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
15. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 receptor alpha chain on acute myelocytic leukemia cells is involved in cell-to-cell interactions.
Nakase K; Kita K; Otsuji A; Anazawa H; Shirakawa S; Nasu K; Dohy H; Tsutani H; Tanaka I
Leuk Res; 1993 Jan; 17(1):17-21. PubMed ID: 8429675
[TBL] [Abstract][Full Text] [Related]
18. Identification and cellular distribution of the rat interleukin-2 receptor beta chain: induction of the IL-2R alpha- beta+ phenotype by major histocompatibility complex class I recognition during T cell development in vivo and by T cell receptor stimulation of CD4+8+ immature thymocytes in vitro.
Park JH; Hanke T; Hünig T
Eur J Immunol; 1996 Oct; 26(10):2371-5. PubMed ID: 8898947
[TBL] [Abstract][Full Text] [Related]
19. IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.
Sasson SC; Smith S; Seddiki N; Zaunders JJ; Bryant A; Koelsch KK; Weatherall C; Munier ML; McGinley C; Yeung J; Mulligan SP; Moore J; Cooper DA; Milliken S; Kelleher AD
Cytokine; 2010 Apr; 50(1):58-68. PubMed ID: 20060740
[TBL] [Abstract][Full Text] [Related]
20. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
